Amylyx Pharmaceuticals (AMLX) FCF Margin Growth (3y) (2024)

Amylyx Pharmaceuticals (AMLX) FCF Margin Growth (3y) (2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 253.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -1,444.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -990.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -2,377.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -1,484.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4,765.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1,067.00
10 Amylyx Pharmaceuticals 1.94 Bn 1.94 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -261,348.00